Partner Content Partner Content PRISYM ID announces six further projects go live PRISYM ID has six new labeling software systems
Partner Content Partner Content Foods, supplements, and medicine: the new frontier in chroni... Chronic diseases are the biggest threat to our global socio-economic development.
Partner Content Partner Content 3 Considerations for Pharma Brand Strategy Success How to reach the right people - with or without cookies
Partner Content Partner Content Continuity of Care in a Pandemic: Reflecting on the Rise of ... Health Union research shows telehealth use has tripled
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
